BU-NOT-SET

CONTACT US
Lyophilisation: Key to overcoming stability hurdles for complex therapeutics
  • Biologics
  • Manufacturing
lyophilisation vials
Insight
Key trends shaping high-potency API manufacturing in 2026
  • Drug product
  • Manufacturing
Lab worker
Insight
Webinar | High potent API manufacturing: Strategies, safety & scale-up
  • Drug product
  • Manufacturing
Office worker
Webinar
Advancing malaria vaccine innovation through collaborative science
  • Biologics
  • Drug product
lab workers in blue suits
Insight
Adapting analytical testing to increasing development complexity
  • Analytical chemistry
  • Drug product
Recipharm_analytical lab Bengaluru
Insight
Navigating high potency OSD manufacturing
  • Drug product
  • Manufacturing
Woman looking at screen
Insight
Sustainable drug delivery systems: Collaborative innovation to shrink pharma’s packaging footprint
  • Manufacturing
  • Sustainability
Pharmaceutical packaging bottles_Recipharm
Insight
ReciPredict - How value by design can bring your drug to market faster
  • Drug product
  • Manufacturing
ReciPredict Recipharm
eBook
Enhancing stability for next-generation therapeutics with lyophilisation
  • Biologics
  • Manufacturing
Lyophilisation_Recipharm
eBook
Insight
  • Industry trends
  • Manufacturing
Today’s potent oral dose forms require flexible manufacturing environments
Insight
  • Analytical chemistry
  • Drug product
Benefits of reformulation strategies
Case study
  • Drug product
  • Manufacturing
Supporting first lyophilised mRNA vaccine to pivotal trial
Fact sheet
  • Drug product
  • Manufacturing
LAB+ blow-fill-seal system
Insight
  • Drug product
  • Manufacturing
How process innovation helped rapidly overcome mRNA drug product finishing and dispensing challenges
Insight
  • Biologics
Bringing virotherapy forward
Case study
  • Drug product
Optimising formulation to improve solubility ready for Phase III
Insight
  • Drug product
  • Industry trends
Trends emerging in capsule dosage form development
Fact sheet
  • Corporate
Licensing portfolio